LivaNova (LIVN)
(Real Time Quote from BATS)
$55.21 USD
-0.73 (-1.31%)
Updated Apr 25, 2024 01:33 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
LIVN 55.21 -0.73(-1.31%)
Will LIVN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for LIVN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LIVN
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
LivaNova (LIVN) Earnings Expected to Grow: Should You Buy?
LIVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
LivaNova (LIVN) Q4 Earnings and Revenues Top Estimates
CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates
Other News for LIVN
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Bigtincan Holdings (ASX:BTH) - Bigtincan's AI Investments Pay Off, Achieves Record Q3 Results with Surge in EBITDA and Free Cash Flow
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
Piper Sandler Keeps Their Buy Rating on LivaNova (LIVN)
NXST, GNTX, and COKE among the best mid-cap technical ideas - Roth MKM